...
首页> 外文期刊>BMC Oral Health >Treatment of recurrent aphthous stomatitis (RAS; aphthae; canker sores) with a barrier forming mouth rinse or topical gel formulation containing hyaluronic acid: a retrospective clinical study
【24h】

Treatment of recurrent aphthous stomatitis (RAS; aphthae; canker sores) with a barrier forming mouth rinse or topical gel formulation containing hyaluronic acid: a retrospective clinical study

机译:用屏障形成的漱口水或含有透明质酸的局部凝胶制剂治疗复发性口疮性口炎(RAS;口疮;溃疡疮):一项回顾性临床研究

获取原文
           

摘要

Use of hyaluronic acid-based products has become a valuable alternative to drug-based approaches in the treatment of recurrent aphthous stomatitis (RAS). The presented study aimed to investigate the effect of a barrier forming hyaluronic acid containing mouth wash or a topical gel formulation on the healing of RAS and patient’s quality of life. For this single-center retrospective study, medical records of the Dental School of the University of Brescia were screened for adult and systemically health patients suffering from minor recurrent aphthous stomatitis (RAS) and treated with either a barrier forming, hyaluronic acid containing mouth wash (GUM? AftaClear? rinse) or a topical gel (GUM? AftaClear? gel) in 2015. All patients fulfilling the in?/exclusion criteria and presenting full data sets on lesion diameter, lesion color, as well as pain perception for baseline (day 0) and 4 and 7?days after treatment were enrolled into the presented study. Out of 60 screened patients, a total of 20 patients treated with the Rinse formulation and 25 treated with the Gel formulation were eligible for the enrollment into this study. Both groups showed equal distribution in patient’s age, sex and presented a similar mean lesion size (3.0?±?1.0?mm), lesion color distribution as well as pain perception at baseline. All patients showed significant normalization of lesion color, reduction of pain, and lesion dimension within the course of their treatment. After 7?days, the mean percentage of lesion reduction was highly significant for both groups attaining 77.4?±?30.1% in the Rinse group and 81.2?±?23.1% in the Gel group with a complete lesion closure obtained in 60 and 56% of the cases, respectively. However, a significant (p??0.05) higher percentage of lesions in the Gel group (72%) compared to the Rinse group (40%) showed an improvement in lesion size already after 3?days. Within the limitation of retrospective design, it can be concluded that both the barrier forming hyaluronic acid containing mouth rinse as well as the topical gel formulation are effective in the treatment of minor recurrent aphthous stomatitis (RAS), with a trend for an earlier healing onset for the topical Gel formulation.
机译:在复发性口疮性口炎(RAS)的治疗中,使用基于透明质酸的产品已成为基于药物的方法的有价值的替代品。提出的研究旨在调查含漱口水的屏障形成透明质酸或局部用凝胶制剂对RAS愈合和患者生活质量的影响。在这项单中心回顾性研究中,对布雷西亚大学牙科学校的医学记录进行了筛查,以发现患有轻度复发性口疮性口炎(RAS)的成年和全身健康患者,并用形成屏障的含透明质酸的漱口水进行治疗(在2015年使用GUM?AftaClear?冲洗液或局部用凝胶(GUM?AftaClear?凝胶)。所有患者均符合in / exclusion标准,并提供有关病变直径,病变颜色以及基线疼痛知觉的完整数据集(每天) 0)以及治疗后4和7天纳入本研究。在60名接受筛选的患者中,共有20例用Rinse制剂治疗的患者和25例用Gel制剂治疗的患者符合入选本研究的条件。两组患者的年龄,性别均分布均匀,平均病变大小(3.0?±?1.0?mm),病变颜色分布以及基线疼痛感相似。所有患者在治疗过程中均显示出明显的病变颜色正常化,疼痛减轻和病变范围。 7天后,两组的平均病变减少率非常高,冲洗组达到77.4±±30.1%,凝胶组达到81.2±±23.1%,分别有60%和56%的病变完全闭合分别。但是,与冲洗组(40%)相比,凝胶组(72%)的病变百分比显着较高(p <0.05)(72%),这表明3天后病变的大小已有改善。在回顾性设计的范围内,可以得出结论,含有屏障的透明质酸漱口液以及局部用凝胶制剂均可有效治疗轻度复发性口疮性口炎(RAS),且有较早治愈的趋势。用于局部凝胶制剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号